Knowledge that Transforms

To make high-quality research more accessible and easier to explore.

Fields:
107 results ✕ Clear filters

JFQ volume 56 Issue 6 Cover and Front matter

Journal of Financial and Quantitative Analysis 2021 56(6), f1-f4 open access
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

JFQ volume 56 Issue 6 Cover and Back matter

Journal of Financial and Quantitative Analysis 2021 56(6), b1-b1 open access
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

JFQ volume 56 issue 7 Cover and Back matter

Journal of Financial and Quantitative Analysis 2021 56(7), b1-b2 open access
Should companies be run for profit or purpose? This book shows how they can deliver both -based on rigorous evidence and an actionable framework. This edition, updated to include the pandemic and latest research, explains how managers, investors and citizens can put purpose into practice -and overcome the difficult trade-offs that hold them back.

JFQ volume 56 issue 8 Cover and Front matter

Journal of Financial and Quantitative Analysis 2021 56(8), f1-f4 open access
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

JFQ volume 56 issue 8 Cover and Back matter

Journal of Financial and Quantitative Analysis 2021 56(8), b1-b4 open access
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

JFQ volume 56 issue 7 Cover and Front matter

Journal of Financial and Quantitative Analysis 2021 56(7), f1-f4 open access
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Where Does the Predictability from Sorting on Returns of Economically Linked Firms Come From?

Journal of Financial and Quantitative Analysis 2021 56(8), 2634-2658 open access
Abstract Cross-firm predictability among economically linked firms can arise when both firms exhibit their own momentum and their returns are contemporaneously correlated. We show that cross-firm predictability can last up to 10 years, which is hard to reconcile with an interpretation of slow information diffusion. However, it is consistent with the economically linked firms’ commonality in momentum. The contribution of each source can be found by decomposing leaders’ returns into the predictable (momentum) and news components. Sorting on each, we find that both sources contribute almost equally to 1-month predictability, whereas commonality in momentum is solely responsible for longer-horizon cross-firm predictability.

Board Gender Diversity and Corporate Innovation: International Evidence

Journal of Financial and Quantitative Analysis 2021 56(1), 123-154
Abstract Using a novel database of firm patents and board characteristics across 45 countries, we examine both within- and cross-country determinants of board gender diversity and its relation to corporate innovation. Boards are more likely to include women in countries with narrower gender gaps, higher female labor market participation, and less masculine cultures. Firms with gender diverse boards have more patents and novel patents, and a higher innovative efficiency. Further analyses suggest that gender diverse boards are associated with more failure-tolerant and long-term chief executive officer (CEO) incentives, more innovative corporate cultures, and more diverse inventors, characteristics that are conducive to an improved innovative performance.

Do Firms Purposefully Change Capital Structure? Evidence from an Investment-Opportunity Shock to Drug Firms

Journal of Financial and Quantitative Analysis 2021 56(3), 915-944
Abstract We study the capital structure changes of drug firms after an investment-opportunity shock brought about by the Biologics Price Competition and Innovation Act. Using a difference-in-difference approach, we show that the shock led drug firms to make their capital structures less constraining by decreasing leverage, shortening debt maturity, increasing unsecured debt, and reducing convertible debt. New debt covenants became less restrictive and firms raised equity to preserve borrowing capacity. Our results support the view that firms actively manage their capital structures to bolster financial flexibility and increase debt capacity in response to new investment opportunities.

Does Securitization Weaken Screening Incentives?

Journal of Financial and Quantitative Analysis 2021 56(8), 2934-2962
Abstract We test whether lenders’ screening incentives weaken when faced with the possibility of loan sales. We adopt a new measure of lending standards, the processing time for mortgage applications at the loan level, and use the collapse of the nonagency mortgage-backed securities issuance market as a natural experiment. Secondary market liquidity for nonconforming loans decreased significantly at the end of 2007, but the market for securitizing conforming loans did not experience the same breakdown. Following this event, lenders spent significantly more time screening applications for loans larger than the conforming loan limits than for those below the limits. The processing-time gap widened more for banks with lower capital, greater involvement in the originate-to-distribute model, and larger assets.